Actively Recruiting
Influences of Propofol and Sevoflurane Anesthesia in Ovarian Cancer (Anesthetics)
Led by Kaohsiung Medical University Chung-Ho Memorial Hospital · Updated on 2023-05-30
416
Participants Needed
1
Research Sites
253 weeks
Total Duration
On this page
Sponsors
K
Kaohsiung Medical University Chung-Ho Memorial Hospital
Lead Sponsor
T
Tri-Service General Hospital
Collaborating Sponsor
AI-Summary
What this Trial Is About
Ⅶ. Study procedures (summary) 1. Written informed consent must be obtained before any study specific procedures are undertaken. Qualified participants were identified at the pre-anesthesia evaluation clinic or ward. The informed consents are obtained from the patient in the ward at night before the operation. 2. The process of the experiment (brief describe) In the preoperative waiting area, the patients are randomly assigned and divided into two groups according to the allocation sequence table (corresponding to 1:1 randomization) generated by the computer. The propofol group was both induced and maintained at an effect-site concentration (Ce) of 2.0-4.0 mcg/mL by a target-controlled infusion (TCI) system. The sevoflurane group was maintained via sevoflurane vaporizer between 1% and 3% (target minimum alveolar concentration of 0.7-1.3). During the operation, the dose of anesthetic drugs (propofol/fentanyl /remifentanil and sevoflurane/cisatracurium/rocuronium) are adjusted to maintain the mean arterial pressure and heartbeat fluctuations within 20% of the baseline value and Entropy (or BIS) value at 40-60in both groups. The following patient data were recorded, the type of anesthesia, sex, age at the time of surgery, preoperative Karnofsky performance status (KPS) score and functional capacity, the postoperative complications within 30 days (according Clavien-Dindo classification), ASA physical status scores, tumor marker ,tumor size, intraoperative blood loss/transfusion, duration of surgery, duration of anesthesia, total opioid (remifentanil/fentanyl) use, postoperative radiation therapy, postoperative chemotherapy, postoperative concurrent chemoradiotherapy, the presence of disease progression, and 6-month, 1-year, 3-year and 5-year overall survival and Karnofsky performance status score were recorded.
CONDITIONS
Official Title
Influences of Propofol and Sevoflurane Anesthesia in Ovarian Cancer (Anesthetics)
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Aged between 20 and 80 years
- ASA physical status class I to III
- Undergoing elective surgery for primary ovarian tumors under general anesthesia
You will not qualify if you...
- Severe mental disorders
- Poor liver function
- Pregnant or lactating women
- Morbid obesity
- History of allergy to any study drugs
- Surgery for non-primary ovarian cancer
- Undergoing ovarian cancer pathological section surgery
- Incomplete medical records
- Combined or emergency surgeries
- Receiving other non-ovarian cancer therapies
- Receiving palliative treatment after ovarian cancer surgery
- Anesthesia maintenance without propofol or sevoflurane
- Use of multiple anesthetics during surgery (e.g., ketamine, dexmedetomidine, other inhalation anesthetics)
- Diagnosed with benign tumors before or after surgery
- Patients with ovarian metastases
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Kaohsiung Medical University Chung-Ho Memorial Hospital
Kaohsiung City, Taiwan
Actively Recruiting
Research Team
Z
Zhi-Fu Wu, MD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
TRIPLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here